Abstract Parkinson`s disease (PD) is a progressive, disabling neurodegenerative disorder with onset of motor and non-motor features. Both reduce quality of life of PD patients and cause caregiver burden. This review aims to provide a survey of possible therapeutic options for treatment of motor and non motor symptoms of PD and to discuss their relation to each other. MAO-B-Inhibitors, NMDA antagonists, dopamine agonists and levodopa with its various application modes mainly improve the dopamine associated motor symptoms in PD. This armentarium of PD drugs only partially influences the onset and occurrence of non motor symptoms. These PD features predominantly result from non dopaminergic neurodegeneration. Autonomic features, such as seborr...
Parkinson's disease (PD) is a progressive disease due to dopaminergic cell lass in the substantia ni...
Although Parkinson's disease (PD) is diagnosed on the basis of motor symptoms, including slowness of...
Parkinson’s disease (PD) is a neurodegenerative disorder that features progressive, disabling motor ...
The main attention in the management of Parkinson's disease is directed on the treatment of motor an...
Parkinson's disease (PD) is a neurodegenerative disorder that features progressive, disabling motor ...
Parkinson's disease is a neurodegenerative pathology which affects the dopaminergic neurons in the m...
Parkinson’s disease is the second most common neurodegenerative disease in the world and yet has no ...
Cardinal motor features of Parkinson’s disease (PD) include bradykinesia, rest tremor, and rigidity,...
Although levodopa and dopaminergic drugs remain the mainstay of therapy for the motor symptoms of Pa...
Over a period of more than 50 years, the symptomatic treatment of the motor symptoms of Parkinson di...
Parkinson’s disease (PD) is a progressive disease due to dopaminergic cell loss in the substantia ni...
Parkinson’s disease (PD) is the second most common neurodegenerative illness that affects the centra...
Parkinson’s disease has a wide variety of motor and non-motor symptoms. Treatment aims to control th...
Introduction: The clinical diagnosis of Parkinson’s disease (PD) is based on the identification of b...
AbstractBackgroundParkinson’s disease (PD) affects about 1% of the over 60 population and is charact...
Parkinson's disease (PD) is a progressive disease due to dopaminergic cell lass in the substantia ni...
Although Parkinson's disease (PD) is diagnosed on the basis of motor symptoms, including slowness of...
Parkinson’s disease (PD) is a neurodegenerative disorder that features progressive, disabling motor ...
The main attention in the management of Parkinson's disease is directed on the treatment of motor an...
Parkinson's disease (PD) is a neurodegenerative disorder that features progressive, disabling motor ...
Parkinson's disease is a neurodegenerative pathology which affects the dopaminergic neurons in the m...
Parkinson’s disease is the second most common neurodegenerative disease in the world and yet has no ...
Cardinal motor features of Parkinson’s disease (PD) include bradykinesia, rest tremor, and rigidity,...
Although levodopa and dopaminergic drugs remain the mainstay of therapy for the motor symptoms of Pa...
Over a period of more than 50 years, the symptomatic treatment of the motor symptoms of Parkinson di...
Parkinson’s disease (PD) is a progressive disease due to dopaminergic cell loss in the substantia ni...
Parkinson’s disease (PD) is the second most common neurodegenerative illness that affects the centra...
Parkinson’s disease has a wide variety of motor and non-motor symptoms. Treatment aims to control th...
Introduction: The clinical diagnosis of Parkinson’s disease (PD) is based on the identification of b...
AbstractBackgroundParkinson’s disease (PD) affects about 1% of the over 60 population and is charact...
Parkinson's disease (PD) is a progressive disease due to dopaminergic cell lass in the substantia ni...
Although Parkinson's disease (PD) is diagnosed on the basis of motor symptoms, including slowness of...
Parkinson’s disease (PD) is a neurodegenerative disorder that features progressive, disabling motor ...